anonymous
Guest
anonymous
Guest
What happened to conjunctivitis product
What happened to conjunctivitis product
Potentially good product but clinical trials too difficult to enroll and will never get approved.What happened to conjunctivitis product
Back to the steroids....Heard BD was the new head of Ocular Therapeutics. Announcing in the next couple weeks
What's your point? Get a job!Back to the steroids....
Lol...I need to explain?What's your point? Get a job!
In other words, they had no clue. Something that can be made up in the clinicPotentially good product but clinical trials too difficult to enroll and will never get approved.
Heard BD was the new head of Ocular Therapeutics. Announcing in the next couple weeks
Has he moved ? Has been quiet at least for 3 yearsThat would actually be a really good thing for Ocular to have Bob over there. The sales force is led by Chad B, former Alcon/ Novartis guy that has never actually sold anything in his life. He comes from the Ops side and is way better at doing burpees than he is at connecting with customers or employees.
Think its pretty well known hes at occular theraputicsBig news coming out soon. BD will be named President and CCO of small start up
Think its pretty well known hes at occular theraputics
Hope so - Dempsey is a proven winner!I don’t think so. I’m hearing something different. Don’t be surprised if he stays at Novartis
Yeah ....insert deflated balloon emoji here..Hope so - Dempsey is a proven winner!